Clinical Trial Update: Etoposide in the First-line Treatment of Adult EBV-HLH [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating etoposide as first-line treatment for adult EBV-HLH (Hemophagocytic Lymphohistiocytosis).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophagocytic Lymphohistiocytosis

Drugs mentioned

• Etoposide (Etoposide)

Snippet

Sponsor: Beijing Friendship Hospital | Conditions: Hemophagocytic Lymphohistiocytosis | Phase 3 | Status: UNKNOWN